Unternehmen Exalenz Bioscience Ltd. TEL AVIV STOCK EXCHANGE
Aktien
IL0011048688
Medizinische Versorgung
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Raffi Werner
CEO | Chief Executive Officer | 65 | 01.10.10 |
Moshe Dori
DFI | Director of Finance/CFO | - | 29.01.19 |
Eitan Blank
COO | Chief Operating Officer | 54 | 01.01.07 |
Ofer Schlesinger
CTO | Chief Tech/Sci/R&D Officer | 59 | 23.07.14 |
Ilan Ben Oren
CTO | Chief Tech/Sci/R&D Officer | 59 | 11.04.06 |
Didier Samuel
PRN | Corporate Officer/Principal | - | - |
Ari Soae
PRN | Corporate Officer/Principal | 46 | 01.01.06 |
Ilan Haikin
AUD | Comptroller/Controller/Auditor | 69 | 21.11.10 |
Gavin Doree
SAM | Sales & Marketing | 47 | 29.07.13 |
Susan Alpert
LAW | General Counsel | 78 | 01.01.11 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Sharon Kochan
BRD | Director/Board Member | 55 | 04.07.16 |
Moshe Arkin
BRD | Director/Board Member | 69 | 01.01.06 |
Hanna Lerman
BRD | Director/Board Member | 51 | 16.04.15 |
Itai Arkin
BRD | Director/Board Member | 35 | 16.04.15 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 26 917 095 | 6 557 013 ( 24,36 %) | 0 | 24,36 % |
Unternehmenskontakt
Meridian Bioscience Israel Ltd.
4 Ha'maayan Street
7177872, Modi'in-Maccabim-Re'ut
+
Sektor
% 1. Jan. | Kap. | |
---|---|---|
-3.79% | 184 Mrd. | |
-0.84% | 107 Mrd. | |
-3.75% | 69.44 Mrd. | |
+3.45% | 50.37 Mrd. | |
+9.04% | 44.82 Mrd. | |
+3.40% | 41.53 Mrd. | |
+3.66% | 26.84 Mrd. | |
+3.21% | 26.73 Mrd. | |
+15.23% | 25.71 Mrd. |